ATE154237T1 - Inhalationspulver enthaltend antistatisches hilfsmittel - Google Patents

Inhalationspulver enthaltend antistatisches hilfsmittel

Info

Publication number
ATE154237T1
ATE154237T1 AT93918018T AT93918018T ATE154237T1 AT E154237 T1 ATE154237 T1 AT E154237T1 AT 93918018 T AT93918018 T AT 93918018T AT 93918018 T AT93918018 T AT 93918018T AT E154237 T1 ATE154237 T1 AT E154237T1
Authority
AT
Austria
Prior art keywords
powder containing
inhalation powder
containing antistatic
antistatic aid
aid
Prior art date
Application number
AT93918018T
Other languages
English (en)
Inventor
Gordon Thomas Rhone-Po Simpkin
Roy Rhone-Poulenc Rore Trunley
Ann-Marie Rhone-Poule Leighton
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of ATE154237T1 publication Critical patent/ATE154237T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93918018T 1992-08-14 1993-08-13 Inhalationspulver enthaltend antistatisches hilfsmittel ATE154237T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9217312A GB2269992A (en) 1992-08-14 1992-08-14 Powder inhalation formulations

Publications (1)

Publication Number Publication Date
ATE154237T1 true ATE154237T1 (de) 1997-06-15

Family

ID=10720370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918018T ATE154237T1 (de) 1992-08-14 1993-08-13 Inhalationspulver enthaltend antistatisches hilfsmittel

Country Status (16)

Country Link
US (1) US5908639A (de)
EP (1) EP0654991B1 (de)
JP (1) JP3787573B2 (de)
AT (1) ATE154237T1 (de)
AU (1) AU678379B2 (de)
CA (1) CA2142126C (de)
DE (1) DE69311556T2 (de)
DK (1) DK0654991T3 (de)
ES (1) ES2106362T3 (de)
GB (1) GB2269992A (de)
GR (1) GR3024468T3 (de)
IL (1) IL106665A (de)
MX (1) MX9304975A (de)
NZ (1) NZ254945A (de)
WO (1) WO1994004133A1 (de)
ZA (1) ZA935943B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1006794B1 (de) 1997-03-12 2007-11-28 Robert W. Esmond Verfahren zur behandlung oder prävention der alzheimerischen krankheit
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4691298B2 (ja) * 1999-10-12 2011-06-01 科研製薬株式会社 粉末吸入用製剤及びその製造方法
NZ518401A (en) 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
WO2001056581A1 (fr) * 2000-02-04 2001-08-09 Kissei Pharmaceutical Co., Ltd. Preparation en poudre pour inhalation et inhalateur de poudre contenant cette preparation
CA2401288A1 (en) 2000-02-28 2001-09-07 Vectura Limited Improvements in or relating to the delivery of oral drugs
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
CN100551358C (zh) * 2000-06-27 2009-10-21 维克多瑞有限公司 用于药物组合物的颗粒的制备方法
AU2002220857A1 (en) * 2000-11-30 2002-06-11 Vectura Limited Particles for use in a pharmaceutical composition
DK1337240T4 (en) 2000-11-30 2015-01-05 Vectura Ltd A process for the preparation of particles for use in a pharmaceutical composition
WO2003020197A1 (en) 2001-09-05 2003-03-13 Vectura Limited Improvements in or relating to the delivery of oral drugs
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
EP1490031A1 (de) 2002-03-07 2004-12-29 Vectura Limited Schnell schmelzende multiteilchen-formulierungen für die orale abgabe
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
EP1607117A4 (de) 2003-03-27 2007-10-24 Bioactis Ltd Applikator für pulvermedikation in der nasenhöhle
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
ES2385934T3 (es) 2004-08-20 2012-08-03 Mannkind Corporation Catálisis de la síntesis de dicetopiperazina.
EP2314298B1 (de) 2004-08-23 2015-05-27 MannKind Corporation Mikropartikel enthaltend Diketopiperazinsalze zur Arzneimitteldarreichung
EP1657278A1 (de) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Beschichtete Calciumcarbonat-Teilchen mit grosser spezifischer Oberfläche
KR20160022404A (ko) 2005-09-14 2016-02-29 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
MX2008010721A (es) 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
EP3281663B8 (de) 2008-06-13 2022-09-21 MannKind Corporation Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (es) 2008-06-20 2011-03-25 Mankind Corp Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
ES2611031T3 (es) * 2008-07-18 2017-05-04 Prosonix Limited Proceso de mejora de la cristalinidad
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2400950T3 (pl) 2009-02-26 2019-12-31 Glaxo Group Limited Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
EP2496295A1 (de) 2009-11-03 2012-09-12 MannKind Corporation Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
BR112012033060A2 (pt) 2010-06-21 2018-02-27 Mannkind Corp métodos de sistema de liberação de fármaco em pó seco
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (de) 2011-10-24 2014-09-17 MannKind Corporation Verfahren und zusammensetzungen zur schmerzbehandlung
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
EP2911690A1 (de) 2012-10-26 2015-09-02 MannKind Corporation Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
EP3587404B1 (de) 2013-03-15 2022-07-13 MannKind Corporation Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives

Also Published As

Publication number Publication date
EP0654991B1 (de) 1997-06-11
DE69311556D1 (de) 1997-07-17
MX9304975A (es) 1994-05-31
JP3787573B2 (ja) 2006-06-21
CA2142126C (en) 2007-01-09
IL106665A (en) 1998-02-22
US5908639A (en) 1999-06-01
EP0654991A1 (de) 1995-05-31
WO1994004133A1 (en) 1994-03-03
GB2269992A (en) 1994-03-02
AU678379B2 (en) 1997-05-29
DE69311556T2 (de) 1997-12-04
JPH08500109A (ja) 1996-01-09
ZA935943B (en) 1994-06-09
AU4725693A (en) 1994-03-15
GB9217312D0 (en) 1992-09-30
ES2106362T3 (es) 1997-11-01
NZ254945A (en) 1996-06-25
IL106665A0 (en) 1993-12-08
DK0654991T3 (da) 1997-12-29
GR3024468T3 (en) 1997-11-28
CA2142126A1 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
DE69417232D1 (de) Intravaginales wirkstoffabgabesystem
FI954098A (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
NO911260D0 (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
EP0446636A3 (en) External application base or auxiliary agent and external application composition for human being or animal containing the same
AU8370491A (en) Antimicrobial peptides and an antimicrobial agent
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
BG103677A (en) Solid mixtures based on sulphonylcarbamides and adjuvants
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
ZA852495B (en) Anticonvulsant agents
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
IE791212L (en) 2- azaergolines and 2 - aza -8 (or9)- ergolines
NO985079L (no) Eksplosiv formulering
GB9312982D0 (en) Active agent delivery systems
HUT67313A (en) Process for prepg. new bacis ethers and pharmaceutical compn.s containing them
GB9010570D0 (en) Agent,and method,for preventing drift of dust
ZA917367B (en) Pharmacologically active compounds and use.
GB9315411D0 (en) Active agent delivery
HRP940696B1 (en) Isoxazole-4-carboxamides and hydroxyalkyllidene-cyanoacetamides, drugs containing these compounds and use of such drugs
BG101119A (en) Analgesic composition
SI0731695T1 (en) Pflaster containing an active substance

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner